In addition to their antihistamine effects, H1-receptor antagonists possess pharmacological properties that
are not uniformly distributed among this class of drugs, such as anti-inflammatory, anti-allergic and antiplatelet activities.
In this paper, Cyclizine (1-benzhydryl-4-methyl-piperazine, I), bromodiphenhydramine (2-[(4-bromophenyl)-
phenylmethoxy]-N, N-dimethylethanamine, II) and some of their new piperazine and ethanolamine derivatives (III-VIII)
inducing changes in substitution of phenyl and amine moieties were synthesized and their acute and chronic antiinflammatory
effects were evaluated by standard pharmacological tests. The results showed that substitution of phenyl by
tolyl, anisol and cumene groups in piperazine family could remarkably decrease acute inflammation in these new drugs.
Also, substitution of dimethylamine by morpholine group could not decrease this inflammation in new synthesized
ethanolamine family. But the results from the cotton pellet-induced granuloma formation in rats showed that none of
drugs (I-VIII) were effective to reduce the chronic inflammation.
Keywords: Acute and chronic anti-inflammation effects, Cyclizine, Bromo diphenhydramine, H1-receptor antagonist,
Piperazine and ethanolamine derivatives.
Rights & PermissionsPrintExport